// App-Quantinova.ai

: The Incidence of Post-Thrombotic Syndrome after the Treatment of Upper Extremity Deep Vein Thrombosis with Oral Rivaroxaban

Researchers

Presenter

  • Kirill Lobastov

Principal Investigators

  • Victor Barinov

  • Iliya Schastlivtsev

  • Leonid Laberko

  • Grigory Rodoman

  • Sergey Zhuravlev

  • Valeriy Boyarintsev

Medical Centers

  • Pirogov Russian National Research Medical University, Moscow, Russia

  • Clinical Hospital no.1 of the Presidents Administration of Russian Federation, Moscow, Russia

  • Central State Medical Academy of the President's Administration of Russian Federation, Moscow, Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Heparin

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A